1. Finsterer J, Scorza FA. Do Not Replace Personal Patient/Doctor Interactions by Electronic Visits in Myotonic Dystrophy Patients. Eur Neurol. 2021;1–2.
2. Wenninger S, Stahl K, Montagnese F, Schoser B. Utility and results from a patient-reported online survey in myotonic dystrophies types 1 and 2. Eur Neurol. 2020;83(5):523–33.
3. Overend G, Légaré C, Mathieu J, Bouchard L, Gagnon C, Monckton DG. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Hum Mol Genet. 2019;28(13):2245–54.
4. Marchini C, Lonigro R, Verriello L, Pellizzari L, Bergonzi P, Damante G. Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet. 2000;57(1):74–82.
5. Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992;355(6360):545–6.